Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$1.27B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$570M |
| 3 |
Chipotle Mexican Grill
CMG
|
+$298M |
| 4 |
Oneok
OKE
|
+$279M |
| 5 |
Ameren
AEE
|
+$252M |
Top Sells
| 1 |
Apple
AAPL
|
+$418M |
| 2 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$407M |
| 3 |
Atlassian
TEAM
|
+$364M |
| 4 |
United Parcel Service
UPS
|
+$342M |
| 5 |
Advanced Micro Devices
AMD
|
+$295M |
Sector Composition
| 1 | Technology | 31.61% |
| 2 | Healthcare | 19.69% |
| 3 | Financials | 10.19% |
| 4 | Industrials | 9.75% |
| 5 | Consumer Discretionary | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Zentalis Pharmaceuticals
ZNTL
$105M
| $431K | ﹤0.01% |
21,499
+11
| +0.1% | +$221 |
|
2002
LegalZoom.com
LZ
$1.84B
| $430K | ﹤0.01% |
39,286
+6
| +0% | +$66 |
|
2003
Midland States Bancorp
MSBI
$385M
| $430K | ﹤0.01% |
20,918
+278
| +1% | +$5.71K |
|
2004
Ramaco Resources Class B
METCB
$1.04B
| $428K | ﹤0.01% |
36,761
+19,817
| +117% | +$231K |
|
2005
Sally Beauty Holdings
SBH
$1.45B
| $428K | ﹤0.01% |
51,094
+9
| +0% | +$75 |
|
2006
AMERISAFE
AMSF
$857M
| $428K | ﹤0.01% |
8,547
+2
| +0% | +$100 |
|
2007
Trupanion
TRUP
$1.86B
| $427K | ﹤0.01% |
15,152
+3
| +0% | +$85 |
|
2008
Avanos Medical
AVNS
$558M
| $424K | ﹤0.01% |
20,971
-6
| -0% | -$121 |
|
2009
TriCo Bancshares
TCBK
$1.48B
| $424K | ﹤0.01% |
13,252
+2
| +0% | +$64 |
|
|
BBT
2010
Beacon Financial Corporation
BBT
$2.2B
| $424K | ﹤0.01% |
21,114
+1
| +0% | +$20 |
|
2011
Leap Therapeutics
LPTX
$11.7M
| $423K | ﹤0.01% |
+358,060
| New | +$423K |
|
2012
Steelcase
SCS
$1.92B
| $423K | ﹤0.01% |
37,912
+1
| +0% | +$11 |
|
2013
Fresh Del Monte Produce
FDP
$1.7B
| $423K | ﹤0.01% |
16,357
+2
| +0% | +$52 |
|
2014
Revolve Group
RVLV
$1.67B
| $422K | ﹤0.01% |
31,020
+1,549
| +5% | +$21.1K |
|
2015
Stellar Bancorp
STEL
$1.61B
| $422K | ﹤0.01% |
19,784
+24
| +0.1% | +$512 |
|
2016
Iovance Biotherapeutics
IOVA
$861M
| $422K | ﹤0.01% |
92,537
+88
| +0.1% | +$401 |
|
2017
Compass Minerals
CMP
$752M
| $421K | ﹤0.01% |
15,058
+2
| +0% | +$56 |
|
2018
PAR Technology
PAR
$1.85B
| $417K | ﹤0.01% |
10,825
+2
| +0% | +$77 |
|
|
AVID
2019
DELISTED
Avid Technology Inc
AVID
| $416K | ﹤0.01% |
15,496
+3
| +0% | +$81 |
|
2020
Live Oak Bancshares
LOB
$1.68B
| $413K | ﹤0.01% |
14,259
+3
| +0% | +$87 |
|
2021
DraftKings
DKNG
$22.7B
| $412K | ﹤0.01% |
14,013
-165,901
| -92% | -$4.88M |
|
|
PACW
2022
DELISTED
PacWest Bancorp
PACW
| $412K | ﹤0.01% |
52,085
+7
| +0% | +$55 |
|
2023
Regenxbio
RGNX
$483M
| $412K | ﹤0.01% |
24,998
+6
| +0% | +$99 |
|
|
MFA
2024
MFA Financial
MFA
$1.05B
| $412K | ﹤0.01% |
42,894
| – | – |
|
2025
Establishment Labs
ESTA
$1.1B
| $411K | ﹤0.01% |
8,376
| – | – |
|